Cynosure Advisors’s Exelixis EXEL Stock Holding History

Cynosure Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,049	Closed	-$281K	–	79
2018 Q2	$281K	Hold	13,049	–	–	0.08%	192
2018 Q1	$289K	Buy	+13,049	New	+$361K	0.07%	179

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cynosure Advisors's EXEL Position: Q3 2018 in Review

Cynosure Advisors sold out of Exelixis (EXEL) in Q3 2018, closing a stake of 13,049 shares — an estimated $281K sold.

Cynosure Advisors first reported a position in EXEL in Q1 2018 and held it in 2 quarters. The position peaked at $289K in Q1 2018. 316 funds tracked by Wall St. Rank hold EXEL as of Q3 2018.

Cynosure Advisors reported no remaining Exelixis position as of Q3 2018 after selling out during the quarter.
Cynosure Advisors sold 13,049 Exelixis shares in Q3 2018, an estimated $281K.
Cynosure Advisors first reported a position in Exelixis in Q1 2018 and held it in 2 quarters.
Cynosure Advisors's Exelixis position peaked at $289K in Q1 2018.
316 funds tracked by Wall St. Rank held Exelixis as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.